NCT03050086View on ClinicalTrials.gov

Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

June 19, 2018

Study Completion Date

June 19, 2018

Conditions
Moderate to Severe Papulopustular Rosacea
Interventions
DRUG

BPX-04 1% minocycline topical gel

once daily administration of topical minocycline gel to face

DRUG

BPX-04 2% minocycline topical gel

once daily administration of topical minocycline gel to face

DRUG

BPX-04 vehicle topical gel

once daily administration of topical minocycline gel to face

Trial Locations (1)

92123

Study Center, San Diego

Sponsors

Lead Sponsor

BioPharmX, Inc.
All Listed Sponsors
lead

BioPharmX, Inc.

INDUSTRY